Since infusion of CAR-T or NK cells alone may be immunosuppressed by the PD-1/PD-L1 axis in the tumor microenvironment, thus affecting the therapeutic effect, in this study, we tested a new combination immunotherapy therapy, namely, CAR-NK cells combined with immune checkpoint inhibitors. The gene discussed is CD274; the disease is neoplasm.